内镜下髓核摘除联合纤维环缝合治疗腰椎间盘突出症临床研究

注册号:

Registration number:

ChiCTR2600117694 

最近更新日期:

Date of Last Refreshed on:

2026-01-27 18:06:53 

注册时间:

Date of Registration:

2026-01-27 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

内镜下髓核摘除联合纤维环缝合治疗腰椎间盘突出症临床研究

Public title:

A clinical study of endoscopic nucleus pulposus removal and annulus fibrosus suturing for treating lumbar disc herniation

注册题目简写:

English Acronym:

研究课题的正式科学名称:

内镜下髓核摘除联合纤维环缝合治疗腰椎间盘突出症临床研究

Scientific title:

A clinical study of endoscopic nucleus pulposus removal and annulus fibrosus suturing for treating lumbar disc herniation

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

廖文君 

研究负责人:

李武 

Applicant:

Liao Wenjun 

Study leader:

Wu Li 

申请注册联系人电话:

Applicant telephone:

+86 724 2305985

研究负责人电话:

Study leader's
telephone:

+86 724 2305814

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lw1887239@163.com

研究负责人电子邮件:

Study leader's E-mail:

lw1887239@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖北省荆门市掇刀区象山大道168号

研究负责人通讯地址:

湖北省荆门市象山大道168号

Applicant address:

No. 168, Xiangshan Avenue, Duodao District, Jingmen City, Hubei Province

Study leader's address:

No. 168, xiangshan avenue, jingmen city, hubei province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

荆门市中心医院,荆楚理工学院附属荆门市中心医院

Applicant's institution:

Jingmen Central Hospital ,Jingmen Central Hospital Affiliated to Jingchu university of Technology

研究负责人所在单位:

荆门市中心医院

Affiliation of the Leader:

Jingmen Central Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-03-033

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

荆门市中心医院医学伦理审查委员会

Name of the ethic committee:

Jingmen Central Hospital Ethics Review Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2025-11-21 00:00:00

伦理委员会联系人:

吴明华

Contact Name of the ethic committee:

Wu MingHua

伦理委员会联系地址:

湖北省荆门市象山大道168号

Contact Address of the ethic committee:

No. 168, xiangshan avenue, jingmen city, hubei province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 724 2305985

伦理委员会联系人邮箱:

Contact email of the ethic committee:

965902464@qq.com

研究实施负责(组长)单位:

荆门市中心医院

Primary sponsor:

Jingmen Central Hospital

研究实施负责(组长)单位地址:

湖北省荆门市象山大道168号

Primary sponsor's address:

No. 168, xiangshan avenue, jingmen city, hubei province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北省

市(区县):

Country:

China

Province:

Hubei

City:

单位(医院):

荆门市中心医院

具体地址:

湖北省荆门市象山大道168号

Institution
hospital:

Jingmen Central Hospital

Address:

No. 168, xiangshan avenue, jingmen city, hubei province

经费或物资来源:

荆门市科学技术研究与开发计划

Source(s) of funding:

Jingmen Science and Technology R&D Plan

研究疾病:

腰椎间盘突出压迫坐骨神经引起下肢放射性疼痛麻木  

Target disease:

Lumbar disc herniation compresses the sciatic nerve, causing radiating pain and numbness in the lower limbs

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

IV期临床试验 

Study phase:

4

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

研究内镜下髓核摘除联合纤维环缝合修复治疗腰椎间盘突出症,是否有利于重建纤维环、降低椎间盘突出复发率、预防椎间盘塌陷。  

Objectives of Study:

To study whether endoscopic nucleus pulposus removal combined with annulus fibrosus suture repair in the treatment of lumbar disc herniation is beneficial to reconstructing the annulus fibrosus, reducing the recurrence rate of disc herniation, and preventing disc collapse.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.腰椎滑脱症;(2)黄韧带增厚或骨化或椎管内占位导致的腰椎椎管狭窄症;(3)、复发型腰椎间盘突出症;(4)、2个或以上手术节段者。

Exclusion criteria:

1. Lumbar spondylolisthesis; 2. Lumbar spinal stenosis caused by thickening or ossification of the ligamentum flavum or space occupation in the spinal canal; 3. Recurrent lumbar disc herniation; 4. Two or more surgical segments.

研究实施时间:

Study execute time:

From 2025-06-01 00:00:00 To 2027-06-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-02-01 00:00:00 To 2027-01-01 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

30

Group:

control group

Sample size:

干预措施:

纤维环缝合

干预措施代码:

Intervention:

Annulus fibrosus suture

Intervention code:

组别:

试验组

样本量:

30

Group:

experimental group

Sample size:

干预措施:

纤维环缝合

干预措施代码:

Intervention:

Annulus fibrosus suture

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖北省 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

荆门市中心医院 

单位级别:

三级甲等 

Institution
hospital:

Jingmen Central Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

比较两组术前、术后 3 d、术后 3、6、12 个月疼痛视觉模拟评分(VAS)、Oswestry功能障碍指数(ODI)评价患者腰腿疼情况和腰椎功能状态、末次随访改良 MacNab 评分标准和复发情况等

指标类型:

主要指标

Outcome:

The pain visual analog scale (VAS) and Oswestry Disability Index (ODI) before surgery, 3 days after surgery, and 3, 6, and 12 months after surgery were compared between the two groups to evaluate pati

Type:

Primary indicator

测量时间点:

术前、术后 3 d、术后 3、6、12 个月

测量方法:

VAS;ODI;改良 MacNab 评分标准

Measure time point of outcome:

Before surgery, 3 days after surgery, 3, 6, and 12 months after surgery

Measure method:

VAS; ODI; modified MacNab scoring system

指标中文名:

椎间盘突出复发率

指标类型:

次要指标

Outcome:

Recurrence rate of lumbar disc herniation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 19 years
最大 Max age 99 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

按照年龄、性别、椎间盘突出类型进行分层;每层内单独生成随机数,按比例分配组别。

Randomization Procedure (please state who generates the random number sequence and by what method):

Stratified according to age, gender, and type of intervertebral disc herniation; random numbers are generated separately in each layer, and groups are allocated proportionally.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

开放标签

Blinding:

Open-label study

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2027年收集足够病例后,统计分析数据,撰写论文,分享原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After collecting enough cases in 2027, statistically analyze the data, write a paper, and share the original data

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

试验组和对照组收集的病例记录手术时间、术中出血量、住院费用、术前及术后的VAS评分、ODI指数作为病例记录表;采用SPSS 31.0进行数据的统计分析,比较两组的手术效果

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The operation time, intraoperative blood loss, hospitalization expenses, preoperative and postoperative VAS scores, and ODI index were collected as case record forms; SPSS 31.0 was used for statistical analysis of the data to compare the surgical effects of the two groups.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-01-27 18:06:47